antidepressant

sleep insomnia clock depression sad
Biotech

J&J's oral add-on aces phase 3 in major depressive disorder

J&J's oral drug improved depressive symptoms and sleep in a phase 3 trial for patients who previously did not benefit from antidepressants alone.
Gabrielle Masson May 29, 2024 11:55am
medicine pills

NRx keeps antidepressant's blockbuster hopes alive despite flop

Apr 30, 2024 11:16am
pills prescription

Neurocrine-Takeda antidepressant hits main mark in phase 2 trial

Apr 23, 2024 10:44am
graphic image of five staffers leaving a door labeled closed below a sign labeled jobs

Eliem axes depression drug, lays off 55% of team to stretch cash

Feb 10, 2023 6:00am
success failure signposts

Relmada rails against 'implausible' phase 3 depression data

Dec 8, 2022 8:55am
Biogen

Sage, Biogen post depression data as FDA filing nears completion

Oct 17, 2022 8:01am